The ROE as of December 2024 (TTM) for Athersys, Inc. (ATHX) is 45.24%

According to Athersys, Inc.’s latest financial reports and current stock price. The company's current ROE is 45.24%. This represents a change of 46.35% compared to the average of 30.91% of the last 4 quarters.

Athersys, Inc. (ATHX) Historical ROE (quarterly & annually)

How has ATHX ROE performed in the past?

The mean historical ROE of Athersys, Inc. over the last ten years is -136.40%. The current 45.24% ROE has changed -133.16% with respect to the historical average. Over the past ten years (40 quarters), ATHX's ROE was at its highest in in the June 2022 quarter at 196.27%. The ROE was at its lowest in in the March 2022 quarter at -7183.71%.

Athersys, Inc. (ATHX) ROE by Quarter and Year

Discovering the peaks and valleys of Athersys, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Athersys, Inc. (ATHX) Average ROE

How has ATHX ROE performed in the past?

The current ROE of Athersys, Inc. (ATHX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Athersys, Inc. (ATHX) ROE vs. Peers

How is ATHX’s ROE compared to its peers?

Athersys, Inc.’s ROE is greater than LianBio (-21.53%), greater than Eton Pharmaceuticals, Inc. (-36.29%), less than Galera Therapeutics, Inc. (14.34%), less than Checkpoint Therapeutics, Inc. (359.97%), greater than YS Biopharma Co., Ltd. (-77.30%), greater than Sonnet BioTherapeutics Holdings, Inc. (-383.41%), greater than ZyVersa Therapeutics, Inc. (-25512.50%), greater than Allarity Therapeutics, Inc. (-328.22%), less than Kiromic BioPharma, Inc. (327.18%), greater than Avenue Therapeutics, Inc. (-473.61%), greater than Hoth Therapeutics, Inc. (-89.69%), greater than Revelation Biosciences, Inc. (-311.33%), greater than NeuroBo Pharmaceuticals, Inc. (-189.12%), greater than Virax Biolabs Group Limited (-115.10%), greater than TransCode Therapeutics, Inc. (-649.01%), greater than Fortress Biotech, Inc. (-240.30%), less than Akebia Therapeutics, Inc. (129.56%), less than Trevena, Inc. (210.71%), less than Reviva Pharmaceuticals Holdings, Inc. (1.15%), greater than Pyxis Oncology, Inc. (-36.23%), greater than Zura Bio Limited (-39.61%), less than eFFECTOR Therapeutics, Inc. (2.18%), less than Altamira Therapeutics Ltd. (783.37%), greater than Elevation Oncology, Inc. (-59.73%),

Build a custom stock screener for Athersys, Inc. (ATHX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Athersys, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Athersys, Inc. (ATHX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Athersys, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.